Prevalence of methicillin-resistant Staphylococcus aureus colonisation in Tasmanian rural hospitalsBrett Mitchell A B E , Alistair McGregor C and Geoffrey Coombs D
A TIPCU, Department of Health and Human Services, GPO Box 125, Hobart, Tas. 7001, Australia.
B James Cook University, Doctoral Student, School of Nursing, Midwifery & Nutrition, Townsville, Qld 4811, Australia.
C Royal Hobart Hospital, Hobart, Tas. 7001, Australia.
D PathWest Laboratory Medicine (WA), Perth, WA 6000, Australia.
E Corresponding author. Email: firstname.lastname@example.org
Healthcare Infection 14(4) 159-163 https://doi.org/10.1071/HI09023
Published: 21 December 2009
A point prevalence study was performed to determine the methicillin-resistant Staphylococcus aureus (MRSA) nasal colonisation rates in Tasmanian rural hospital inpatients. Nasal swabs were performed on all Tasmanian rural hospital inpatients hospitalised for more than 48 h before collection. A single swab was collected from both anterior nares and cultured for MRSA. Molecular typing was performed on all MRSA isolated. Demographic and clinical data was collected for each study participant. Data was analysed using the statistical software program SPSS. A total of 185 patients from 14 rural hospitals were included in the study. MRSA was isolated from 13 (7%) patients. Significant differences in MRSA prevalence were found between regions (P < 0.05) and between hospitals (P < 0.05). In the northern region of Tasmania, 11% of rural inpatients were colonised with MRSA, compared with 3 and 0% of rural inpatients in the State’s north-west and southern regions, respectively. The presence of an indwelling urinary catheter was associated with a higher risk of MRSA nasal colonisation (P = 0.066). Patient age, gender and duration of hospital admission before the swab was collected were not identified as significant risk factors for MRSA nasal colonisation. Twelve of the 13 MRSA (92%) isolated were characterised as ST22-MRSA-IV (EMRSA-15). There is a higher prevalence of MRSA nasal colonisation in rural hospital inpatients in the northern region of Tasmania compared with other Tasmanian regions. ST22-MRSA-IV may be endemic in at least one northern Tasmanian rural hospital. This information may have implications for future strategies designed to minimise the prevalence and transmission of MRSA in Tasmania.
The researchers would like to acknowledge the assistance of all participating rural hospitals and the staff of the Microbiology Department at the Royal Hobart Hospital. We are grateful to the Gram-positive Bacteria Typing and Research Unit (PathWest Laboratory Medicine, Perth, Western Australia) for the molecular typing of the MRSA isolates.
 Gould I. Costs of hospital-acquired methicillin resistance Staphylococcus aureus (MRSA) and its control. Int J Antimicrob Agents 2006; 28 379–84.
| CrossRef | CAS | PubMed |
 Peterson L, Hacek D, Robicsek A. 5 Million lives campaign. Case study: an MRSA intervention at Evanston Northwestern Healthcare. Joint Comm J Qual Patient Saf 2007; 33 732–8.
 Collignon P, Looke D, Ferguson J, McLaws M, Olsen D. Surveillance definitions for multi-resistant organisms (MROs). Aust Infect Control 2002; 7 8–12.
 Nimmo G, Pearson J, Collignon P, Christiansen K, Coombs G, Bell J, et al. Prevalence of MRSA among Staphylococcus aureus isolated from hospital inpatients, 2005: report from the Australian Group for Antimicrobial Resistance. Commun Dis Intell 2007; 31 288–96.
| PubMed |
 Eveillard M, de Lassence A, Lancien E, Barnaud G, Ricard J, Joly-Guillou M. Evaluation of a strategy of screening multiple anatomical sites for methicillin-resistant Staphylococcus aureus at admission to a teaching hospital. Infect Control Hosp Epidemiol 2006; 27 181–4.
| CrossRef | PubMed |